Abstract: Fluid treatment elements and methods for treating fluids may be used to treat fluids, including gases, liquids, or mixtures of gases, and/or solids, in a crossflow mode of operation. For example, some fluid treatment elements and methods may be used to remove one or more substances from the fluid and may then function as concentrators or filters or separators. Other fluid treatment elements or methods may be used to transfer substances between two fluid streams and may then function as mass transfer devices.

Abstract: A lighting system operating using a digital mirror as its operative device. The digital mirror is used to shape the light which is a passed through advanced optical devices in order to produce an output.

Abstract: A method and apparatus for providing power to e.g., a chargeable device via a radio frequency link. In one aspect, a method of providing power to a chargeable device via radio frequency link comprises generating a substantially un-modulated signal. The method further comprises radiating a substantially un-modulated radio frequency (RF) signal to the chargeable device via a transmit antenna based on the substantially un-modulated signal. The method further comprises powering or charging the chargeable device with power delivered by the substantially un-modulated RF signal.

Abstract: Indolylmaleimide derivatives comprising either a substituted phenyl, naphthyl, tetrahydronaphthyl, quinazolinyl, quinolyl, isoquinolyl or pyrimidinyl residue have interesting pharmaceutical properties, e.g. in the treatment and/or prevention of T-cell mediated acute or chronic inflammatory diseases or disorders, autoimmune diseases, graft rejection or cancer.

Abstract: Indolylmaleimide derivatives comprising either a substituted phenyl, naphthyl, tetrahydronaphthyl, quinazolinyl, quinolyl, isoquinolyl or pyrimidinyl residue have interesting pharmaceutical properties, e.g. in the treatment and/or prevention of T-cell mediated acute or chronic inflammatory diseases or disorders, autoimmune diseases, graft rejection or cancer.

Abstract: A method and system for providing power to a chargeable device via radio frequency link are provided. In one aspect, a method of providing power to a chargeable device via radio frequency link comprises generating a substantially unmodulated signal. The method further comprises radiating a substantially unmodulated radio frequency (RF) signal to the chargeable device via a transmit antenna based on the substantially unmodulated signal. The method further comprises powering or charging the chargeable device with power delivered by the substantially unmodulated RF signal.

Abstract: Indolylmaleimide derivatives comprising either a substituted phenyl, naphthyl, tetrahydronaphthyl, quinazolinyl, quinolyl, isoquinolyl or pyrimidinyl residue have interesting pharmaceutical properties, e.g. in the treatment and/or prevention of T-cell mediated acute or chronic inflammatory diseases or disorders, autoimmune diseases, graft rejection or cancer.

Abstract: A method is disclosed for calculating a transition monitor value for one or more milk-producing animals so as to enable its use in evaluating and optimally managing the health and productivity (i.e., the transition performance) of those individual animals and of their herds. An expected milk production is calculated for a given time period of a current lactation based both on the individual's performance in her previous lactation and on her current state. Transition monitor values are calculated as the difference between actual and expected milk production values. The transition monitor values can then be used to evaluate and to optimize the health and productivity of both individuals and herds of individuals and to make comparisons of transition monitor programs both within and between herds.

Abstract: Disclosed are pyrimidine derivatives of formula wherein R0, R1, R3 to R9, and Z have a signification as indicated in claim 1, which have interesting pharmaceutical properties.

Abstract: There are provided compounds of formula I Wherein X, R1, R2, R3, R4, R5, R6, R7, R8 and R9 are as indicated in claim 1, useful in disorders where ZAP-70 and/or Syk inhibition plays a role or caused by a malfunction of signal cascades connected with FAK.

Abstract: Disclosed are compounds of formula I: wherein R1, R2, R3 and X are as defined herein, in free or salt form, which are useful as CCR5 inhibitors, e.g. in the prevention or treatment of disorders mediated by interactions between chemokine receptors and their ligands.

Abstract: The invention provides a method of alleviating the effects of stress in a non-human animal comprising administering a therapeutically effective amount of a corticosteroid, such as dexamethasone, alone or in conjunction with a nutritional supplement, to the animal in need thereof. The corticosteroid can be administered prior to exposure to the stress, during the stress, and/or following exposure to the stress. The administration of the corticosteroid in conjunction with a nutritional supplement provides synergistic effects in alleviating the effects of stress, particularly weight loss. The nutrient therapy comprises one or more sources of electrolytes providing each of sodium, potassium and magnesium; one or more sources of amino acids providing each of alanine, lysine, phenylalanine, methionine, threonine, leucine, isoleucine, valine, and glutamate; and a source of tryptophan. The combined administration appears to have a restorative effect.